Report Highlights

The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.

Report Includes

154 data tables and 46 additional tables

An analysis of the global market for high-throughput screening (HTS) technologies

Analyses of the global market trends, with market revenue data (sales figures) from 2021 and 2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue growth prospects, along with a market share analysis by component, application, technology type, detection method, end user, and region

Facts and figures pertaining to key market dynamics, technology advances, regulations, and the impact of macroeconomic factors

Insights derived from the Porter’s Five Forces model, as well as global supply chain analyses

Analysis of patent activity, featuring key granted and published patents

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Company profiles of leading players, including Danaher Corp., Thermo Fisher Scientific Inc., Charles River Laboratories, Revvity and Bio-Rad Laboratories Inc.

Report Scope

The current report will provide detailed exposure to the high-throughput screening (HTS) market. This report analyzes the market trends of HTS with data from 2023, estimates from 2024, projections of compound annual growth rates (CAGRs) through 2029 (forecast period is from 2024 through 2029) and regional HTS markets. This report will highlight the current and future market potential of HTS and present a detailed analysis of the competitive environment. It will also cover regulatory scenarios, drivers, restraints and opportunities. Lastly, it presents the market share for key market players.

The market scope in this report is segmented into detection method, component, technology and end user. The report covers spectroscopy, mass spectrometry, chromatography, calorimetry, X-ray diffraction and microscopy based on detection methods. These detection methods are further classified into subcategories for this report. The market is segmented based on components into instruments/

platforms, consumables (e.g., reagents, kits), services and software, and analytics (e.g., bioinformatics). The market is segmented based on technology: cell-based assays, ultra-high-throughput screening, label-free technology and lab-on-a-chip. End users are segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), research and government institutes, and lab and pathological practices.

The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific and other world regions. The regional segment will cover a detailed analysis of major countries, including the U.S., Canada, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. Data from 2023 will be provided as the base year for market estimates, with forecasts for 2024 through 2029.

The report’s goals include:

Analyzing technologies, components, end users and applications.

Analyzing global market size and segmentation.

Understanding market constraints and drivers.

Providing detailed market forecasts for 2029.

Assessing market shares, competitiveness and industry structure.

Identifying potential long-term impacts on the high-throughput screening market.